NIKKEI 225
27,995.17 -167.66 (-0.60%) HANG SENG
17,866.11 +568.17 (+3.28%) CRUDE OIL
77.38 +0.14 (+0.18%) GOLD FUTURES
1,744.80 +4.50 (+0.26%) DOW
33,849.46 -497.57 (-1.45%) BTC-GBP
13,573.27 +44.55 (+0.33%)
Johnson & Johnson (JNJ)
After hours:
| Previous close | 177.24 |
| Open | 176.75 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 900 |
| Day's range | 176.56 - 177.77 |
| 52-week range | 155.72 - 186.69 |
| Volume | |
| Avg. volume | 7,026,070 |
| Market cap | 466.839B |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | 31.32 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 4.52 (2.62%) |
| Ex-dividend date | 21 Nov 2022 |
| 1y target est | N/A |
- Business Wire
Johnson & Johnson to Acquire Abiomed
NEW BRUNSWICK, N.J. & DANVERS, Mass., November 01, 2022--Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, and Abiomed (NASDAQ: ABMD), a world leader in breakthrough heart, lung and kidney support technologies, today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire through a tender offer all outstanding shares of Abiomed, for an upfront payment of $380.00 per share in cash, corresponding to an
- Business Wire
Johnson & Johnson Reports Q3 2022 Results
NEW BRUNSWICK, N.J., October 18, 2022--Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2022. "Our third quarter performance demonstrates our continued strength and resilience across all three of our businesses," said Joaquin Duato, Chief Executive Officer. "Through the ongoing efforts of our teams around the world, we continue to navigate the dynamic macroeconomic environment and remain focused on delivering transformative healthcare solutions. Looking ahead, I remain con
- Business Wire
Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference
NEW BRUNSWICK, N.J., October 03, 2022--Johnson & Johnson (NYSE: JNJ) will participate in the Credit Suisse 31st Annual Global Healthcare Conference on Thursday, November 10th, 2022 at the Terranea Resort in Rancho Palos Verdes, CA. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 12:50 p.m. (Eastern Time).
